https://www.chemistanddruggist.co.uk/CD136202/GP-view-Pharmacy-cancer-scan-plan-leaves-more-questions-than-it-answers I miss the comments under the articles, but despite knowing that almost no-one will read this post... ...I just wanted to applaud the last two paragraphs in Toni's piece above. Universally applicable across healthcare these days, and many other walks of life, too. 

I can't seem to connect

Welcome to C+D's ninth Big Debate.  Tonight’s discussion will focus on the question: “Do online outlets pose a threat to community pharmacy’s reputation?” Some online pharmacy businesses are flourishing, with the pandemic further priming the field for distance-selling outlets. However, the General Pharmaceutical Council last month revealed it had  187 open fitness-to-practise cases linked to 83 online pharmacies and, last year, it said it was considering “differentiated fees options to cover the increased regulation needed for online pharmacies”. So, should community pharmacies embrace the digital model and can these different models coexist? What safety improvements should online pharmacies implement?  Could community pharmacies learn something from online outlets? We’ve got three speakers lined up to share their views tonight, but you can also let us know your thoughts by commenting and asking questions. The “live” part of the debate will close at 8pm, but feel free to continue to exchange views for as long as you like. C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. This debate will start at 7pm.

Inspired by this Twitter thread...here's your chance to pay tribute to community pharmacy and thanks those individuals who have inspired you along the way. (Add yours by commenting below) Clare Howard, clinical lead for medicines optimisation at Wessex Academic Health Science Network (AHSN) “I would like to thank England Pharmacy in Wigan for opening the door to the world of pharmacy to me. I started there in 1988 as a Saturday girl. I had been a waitress (a job I hated) and so it was lovely to start work in a family-run, busy, friendly community pharmacy in Gidlow, Wigan. I am so grateful to Mr England for letting the clumsy, clueless girl that I was, loose on the customers and patients of Gidlow.  “All human life was there. I learned so much in that job. Firstly, I have never laughed so much. The ‘girls’ who worked in the shop and dispensary were all so good to me and the banter was priceless. But I also saw real hardship too: people with serious addiction problems; older people struggling with their mobility; as well as the usual community pharmacy bread and butter of pregnancy testing, children's illness, long-term conditions and people seeking advice and reassurance from a professional person in their high street.  “These formative years have shaped my career. You cannot work in a pharmacy like England's and not see how important community pharmacy is to the people it serves. I saw the GPs and nurses in the practice across the road as part of the team I was in – we must preserve this model of care close to home.  “I had no idea then that this part-time job would open up to me a career that has given me so much. I have worked in all sorts of pharmacy roles, but I have never forgotten the things I learned at the start. Thank you Mr and Mrs England, I am forever in your debt.”    Neelm Saini, pharmacist manager at Cookham Pharmacy in Berkshire “I began my community pharmacy career at the age of 16, working on ‘cash’n’wrap’ (aka the till) at Boots in Redhill for four hours each Saturday. This continued while I completed my GCSEs, A-Levels and degree, and developed from working on the till to other shop duties, but most importantly for me, I was trained to work behind the chemist counter. “The branch manager at the time was Mr Burridge and he was a fine example of a gentleman and a pharmacist. Nothing phased him and I can only ever remember him smiling, being forever present on the shop floor – the true face of the pharmacy. Margaret and Jenny were two other pharmacists that worked at the branch. Jenny (bless her) had the tough time of introducing me to the dispensary on a day when they were short staffed. “In my early days, I recall placing an order for 100 plastipak syringes – except I didn’t appreciate that they came in outers of 100 and so I was welcomed the next morning by a wall of 100 boxes. Let’s just say I wasn’t popular that day! Pre-regs came and went and I was inspired. Sarah was one that I will always remember. Her last day was a very eventful Saturday…I don’t think what she went through that day is even listed in the official competencies! But she made it. “Denise Ede took me though my pre-reg at Boots in Horley. She was fantastic! I had THE best pre-reg year with a brilliant tutor. Her advice on my first day has always stuck with me: ‘Start the day with a clear and organised bench.’”   Ade Williams, lead prescribing pharmacist at Bedminster Pharmacy in South Bristol and director and superintendent pharmacist of the M J Williams Pharmacy Group “Traherne Pharmacy in Hove was across the road from us when I arrived to live in Hove with my aunt. I walked past it every day on my way to college and my aunt – a nurse – advised me to chat to the pharmacist about his career. “He completely sold it to me. It was the richness of the humanity and the access I loved. A local NHS bastion, always with a friendly, welcoming ambience.”   Bruce Warner, NHS England’s deputy chief pharmaceutical officer “Once I qualified from Sunderland [university], I followed my heart to the north west where by now wife was also doing her pre-reg year – being brought up in the home counties it was certainly very different. I did my pre-reg in Boots in Wigan (what a great place!) and then went on the obligatory ‘milk round’ with Boots all over Merseyside. “I remember very soon after I had qualified, I was working in the St Helen’s branch when an elderly man came up to the dispensary counter and asked to speak to the pharmacist. The dispenser said ‘certainly’ and came to fetch me. As I walked out, the patient took one look at me and said: ‘He won’t know anything’ and simply walked off. I was crushed, a newly qualified pharmacist low on confidence and trying to establish himself in the workplace and the profession. “I reflected on that for a long time and in hindsight decided the patient was probably right – a few weeks after qualifying I knew nothing. I want to thank that patient for making me realise that there is absolutely no substitute for experience and actually doing the job. That sixth sense that only develops over time that something is not quite right – there are no shortcuts, no matter how well you are trained. “I have never forgotten the look on that patient’s face or how I felt that morning and would like to think I became a much better pharmacist as a result of that experience. I owe that patient a debt of gratitude for setting me off on the right foot and helping me realise that without the confidence of the patient, we as pharmacists are helpless.”    

Boots UK’s parent company has given prospective bidders until May 16 to submit their final offers for the multiple, Sky News has reported. The news outlet reported today (April 26) that Walgreens Boots Alliance’s advisers at Goldman Sachs have notified bidders of the mid-May deadline for formal offers. Asda’s owners – billionaire Issa brothers and TDR Capital – and the asset management company Apollo Global Management are expected to put forward final offers for the UK community pharmacy chain, Sky News reported. However, the outlet claimed that the multiple is expected to receive “fewer than a handful of bids” by the given deadline. This is due to some parties being put off by the asking price set by Boots’ parent company and “the backdrop of inflation and other cost pressures expected to hamper Boots' near-term financial performance”, Sky News reported. What do you think of the latest Boots sale news? Are you keeping up with it? Are you surprised the multiple has only received a handful of bids? 

My name is Dr Julian Spinks and I am a general practitioner with a specialist interest in the management of incontinence. The proposal to make low-dose oxybutynin (Aquiette) available through pharmacies needs to be viewed against a background of the large number of women who suffer from urinary incontinence caused by overactive bladder. Despite the increasing visibility of incontinence products in adverts, incontinence continues to be a condition which is associated with significant embarrassment and stigma. This often leads to long delays before women seek help from healthcare professionals. These women miss out on early opportunities to treat the underlying cause of their incontinence, such as overactive bladder. Widening the availability of treatment with low-dose oxybutynin through pharmacies offers women with the early stages of overactive bladder an additional way to receive the help they need if they do not wish to consult their GP or a continence service. Oxybutynin is already widely in use as a prescription-only treatment for overactive bladder and, together with other anticholinergic bladder drugs, remains recommended by NICE as a first-line prescribed pharmacological treatment for overactive bladder following bladder training (Bladder training is a way of teaching the bladder to hold more urine and helps to reduce the number of times a person needs to pass urine and to reduce incontinence) Long-term use Oxybutynin is not suitable for some women, particularly older women who are at a greater risk of physical or mental decline and NICE recommends it is not used in this group. The current proposal is for short-term (12 weeks maximum), low-dose, oxybutynin in 18 to 65 year-olds. This would only be offered after a pharmacist has assessed to ensure it is appropriate to use in the individual. The dose and duration proposed are highly unlikely to present the same concerns than long term use of higher-dose anticholinergic medications on prescription. The oxybutynin is being offered together with bladder training. This offers an opportunity for the woman to reduce the progression of her overactive bladder and should diminish the need for ongoing pharmacological treatment at the end of the course. An additional proposed protection is that those women who continue to have problems will be advised to seek advice from their doctor or from a continence service. Given the large numbers of women who do not seek help but continue to suffer from urinary incontinence due to overactive bladder, I view the availability of low-dose oxybutynin through pharmacies to be an extremely positive development and an important way to improve women’s health.

Why would a pharmacist refuse to sell me, a pensioner, a common medical product I have used throughout my life to treat an occasional condition to good effect? I ask because that is what happened to me this week at my local chemists. The condition was an eye infection - a stye - and the product I sought to buy was Gold Eye Ointment, which I have always found to be easily available. My experience began when, with red, inflamed eye, I was asked by the counter assistant why I wanted the product. I then stood there - feeling somewhat vilified - while the assistant held a lengthy discussion with the pharmacist, to be told he would hold a consultation with me. If I had wanted a consultation I would have seen a GP. The pharmacist then became involved in a consultation with a mother and child, on the shop floor and I decided to leave. He spoke to me as I was leaving and I asked if he would allow me to buy the product - he said no. I purchased the product a short while later from a chemist in the same group a few miles away. The assistant merely asked two questions relating to contact lenses and diabetes. Having read the many articles on this site and elsewhere relating to big developments with pharmacists regarding consultations and fast-track training to become GPs - and the great enthusiasm and, in some cases zeal, created - I understand the drive to offer a better public service. But where are the checks and balances? In my case, and I suspect many others, I was denied the simple opportunity to treat a condition I knew with a product I've known and used since childhood without ill effect. How is this improving anything?